Patent details

Basic Information

Publication number:

EP2885003

PCT Application Number:

US2013054848

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137510582

PCT Publication Number:

WO2014028566

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR

French Title of Invention:

COMBINAISON DE PI3K INHIBITEUR ET DE C-MET INHIBITEUR

German Title of Invention:

KOMBINATION VON PI3K INHIBITOR UND C-MET INHIBITOR

SPC Number:

Dates

Filing date:

14/08/2013

Grant date:

29/09/2021

EP Publication Date:

24/06/2015

PCT Publication Date:

20/02/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/09/2021

EP B1 Publication Date:

29/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/08/2022

Expiration date:

14/08/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/09/2021

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

CAPONIGRO, Giordano

Address:

United States (US)

2

Name:

WANG, Hui-Qin

Address:

United States (US)

3

Name:

LEHAR, Joseph

Address:

United States (US)

4

Name:

HUANG, Xizhong

Address:

United States (US)

Priority

Priority Number:

201261683790 P

Priority Date:

16/08/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 45/06; A61K 31/427; A61K 31/4745; A61K 31/5377; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202139

Publication date:

29/09/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages